The introduction of a new ‘modern claims’ system in Malaysia has been welcomed by industry players as it could drive more clinical research, expand new product options for consumers, and open local and international market opportunities.
Pacific health researchers are starting clinical trials in early 2024 to explore kava as an alternate treatment for post-traumatic stress disorder (PTSD).
